Who Wins the Battle Against Obesity? A Network Meta‐Analysis Comparing Tirzepatide and Semaglutide

ABSTRACT Introduction Pharmacological therapies are recommended for individuals with obesity. Semaglutide, a glucagon‐like peptide‐1 receptor agonist (GLP‐1), and tirzepatide, a dual glucose‐dependent insulinotropic polypeptide and GLP‐1 receptor agonist (GIP/GLP‐1), are among the leading pharmacolo...

Descrición completa

Detalles Bibliográficos

Principais autores:	Julia C. Bernardi, Deivyd V. S. Cavalcante, Ramon Huntermann, Maria E. Molinari, Luana Z. Zanon, Jacinthe Khater, Victor A. Gomez, Caroline O. Fischer‐Bacca
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2026-02-01
Series:	Journal of Diabetes
Assuntos:	obese patients reduction of body weight semaglutide tirzepatide
Acceso en liña:	https://doi.org/10.1111/1753-0407.70192
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!